DUBLIN--(BUSINESS WIRE)--The "Artificial Organs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023" report has been added to ResearchAndMarkets.com's offering.
According to the report, the global artificial organs market reached a value of US$ 12 Billion in 2017. The market is expected to reach a value of US$ 21 Billion by 2023, registering a CAGR of 9.5% during 2018-2023.
Rapidly ageing global population and a subsequent increase in the number of people suffering from organ failures represent the key factors driving the artificial organs market. Frequent road accidents and injuries leading to amputations coupled with growing public awareness about advancements in the medical technology have resulted in the demand for artificial organs.
On the other hand, high implantation cost and limited surgical expertise in most regions are expected to restrain the growth of the market. However, the unavailability and scarcity of organ donors at the time of requirement has encouraged the development of artificial organs technology across the globe.
The report has segmented the market on the basis of type including artificial kidney, artificial heart, cochlear implants, and artificial pancreas. Amongst these, artificial kidney represents the largest product type.
On a regional-basis, the report covers North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Currently, North America dominates the market, followed by Europe and Asia-Pacific.
- Abiomed Inc.
- Heartware International Inc.
- Edwards Lifesciences Corp
- Boston Scientific Corporation
- Cochlear Limited
Key Topics Covered
2 Scope and Methodology
3 Executive Summary
5 Global Artificial Organs Market
6 Market Breakup by Type
7 Market Breakup by Region
8 Competitive Landscape
For more information about this report visit https://www.researchandmarkets.com/research/rf9k4h/global_artificial?w=4